Delmar Pharmaceuticals

Get Full Access

Description

  • DelMar Pharmaceuticals, Inc. (NASDAQ: DMPI) is a biopharmaceutical company focused on developing and commercializing new cancer therapies in indications where patients are failing or have become intolerable to modern targeted or biologic treatments. The companys clinical stage program, VAL-083, is a first-in-class small-molecule chemotherapeutic that has been extensively studied by the U.S. National Cancer Institute and is approved in China for the treatment of lung cancer and chronic myelogenous leukemia. Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types, including glioblastoma multiforme (GBM), non-small cell lung cancer (NSCLC) and other solid tumors. DelMar is currently conducting clinical trials in the U.S. with VAL-083 for the treatment of refractory GBM. DelMars research demonstrates that VAL-083 exhibits its anti-tumor activity via a novel mechanism of action that could provide improved treatment options for patients whose tumors exhibit phenotypes that are unlikely to respond to currently available therapy.
  • location

    Headquarters:999 Brdwy W Suite 720 Suite 720, Vancouver, , United States

    More
  • Delmar Pharmaceuticals phone

    Phone Number: +1 604-629-5989

  • Delmar Pharmaceuticals website

    Website: https://www.delmarpharma.com

  • Delmar Pharmaceuticals employees

    Employees:8

  • Delmar Pharmaceuticals revenue

    Revenue:$1 - 10M

  • Delmar Pharmaceuticals legal name

    Legal Name:Delmar Pharmaceuticals

  • Delmar Pharmaceuticals's Social Media

    Delmar Pharmaceuticals linkedin Delmar Pharmaceuticals facebook Delmar Pharmaceuticals twitter
  • done Is this data correct?
  • |  NAICS Code: 541714  |

    Show More
Person level website identification

Co-Founder for Delmar Pharmaceuticals

Jeffrey Bacha

Co-Founder

Person level website visitor identification

Sell more in less time!

Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!

View Employees

Jeffrey Bacha

Co-Founder

Harley Xu

Vice President, Drug Product Development And Cmc

Robert Toth

Director

Lei Liu

Business Development Director

Frequently Asked Questions regarding Delmar Pharmaceuticals

  • Where are Delmar Pharmaceuticals's Headquarters?

    Delmar Pharmaceuticals's Headquarters are in 999 Brdwy W Suite 720 Suite 720,Vancouver,,United States

  • What is Delmar Pharmaceuticals's phone number?

    Delmar Pharmaceuticals's phone number is +1 604-629-5989

  • What is Delmar Pharmaceuticals's official website?

    Delmar Pharmaceuticals's official website is https://www.delmarpharma.com

  • What is Delmar Pharmaceuticals's Revenue?

    Delmar Pharmaceuticals's revenue is $1 - 10M

  • What is Delmar Pharmaceuticals's NAICS code?

    Delmar Pharmaceuticals's NAICS code is 541714

  • How many employees are working in Delmar Pharmaceuticals

    Delmar Pharmaceuticals has 8 employees

  • What is Delmar Pharmaceuticals's Industry?

    Delmar Pharmaceuticals is in the industry of Pharmaceuticals

  • Who is Delmar Pharmaceuticals's Co-Founder?

    Delmar Pharmaceuticals's Co-Founder is Jeffrey Bacha

Company Directory